Phase II study of low-dose topotecan in myelodysplastic syndromes: a Hoosier Oncology Group (HOG) study

Author: Vaena D.A.   Walker P.   Pennington K.   Stephens A.   Stender M.J.   Yiannoutsos C.T.   Young C.   Stoner C.   Cripe L.D.  

Publisher: Elsevier

ISSN: 0145-2126

Source: Leukemia Research, Vol.28, Iss.1, 2004-01, pp. : 49-52

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content